These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2167887)

  • 1. Hypoplasia of bone marrow secondary to sodium antimony gluconate.
    Mallick BK
    J Assoc Physicians India; 1990 Apr; 38(4):310-1. PubMed ID: 2167887
    [No Abstract]   [Full Text] [Related]  

  • 2. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced ventricular tachycardia in kala-azar.
    Krishnan S; Tuteja A; Gupta HL; Prakash SK
    J Indian Med Assoc; 1987 Feb; 85(2):52-4. PubMed ID: 3039008
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 5. Harmful effect of high stibogluconate treatment of kala-azar in India.
    Thakur CP
    Trans R Soc Trop Med Hyg; 1986; 80(4):672-3. PubMed ID: 3027929
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 9. Kala azar--diagnostic dilemma.
    Raman TS; Ahuja SA; Mani KV; Jalpota YP; Adaval SK
    Indian Pediatr; 1992 Aug; 29(8):1036-9. PubMed ID: 1334051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of visceral leishmaniasis].
    Bardzhadze BG
    Med Parazitol (Mosk); 1979; 48(6):11-6. PubMed ID: 229392
    [No Abstract]   [Full Text] [Related]  

  • 11. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy.
    Hernández JA; Navarro JT; Force L
    Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure and 9th, 10th nerve palsy in patient of kala-azar treated with stibanate.
    Rai US; Kumar H; Kumar U; Amitabh V
    J Assoc Physicians India; 1994 Apr; 42(4):338. PubMed ID: 7860562
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient.
    Donovan KL; White AD; Cooke DA; Fisher DJ
    J Infect; 1990 Jul; 21(1):107-10. PubMed ID: 2166765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does antimony therapy cause bleeding in kala-azar patients and why?
    Chowdhury MA; Ahasan HA; Azhar MA; Rafiqueuddin AK; Islam MR; Misbahuddin M; Rashid MU
    Trop Doct; 1995 Oct; 25(4):188-9. PubMed ID: 7502336
    [No Abstract]   [Full Text] [Related]  

  • 18. Antileishmanial activity of antimonials entrapped in liposomes.
    New RR; Chance ML; Thomas SC; Peters W
    Nature; 1978 Mar; 272(5648):55-6. PubMed ID: 203863
    [No Abstract]   [Full Text] [Related]  

  • 19. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate.
    Balzan M; Fenech F
    Trans R Soc Trop Med Hyg; 1992; 86(5):515-6. PubMed ID: 1335622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.